GRCE NASDAQ
Grace Therapeutics, Inc.
1W: -2.4%
1M: -3.3%
3M: -18.2%
YTD: -43.4%
1Y: -32.6%
$2.07
+0.03 (+1.47%)
Weekly Expected Move ±5.6%
$2
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-05-07
Earliest Filing
2023-10-23
Latest Filing
supplier: 1
acquirer: 1
target: 1
partner: 1
Counterparties (Filed by GRCE)
4 relationshipsCompanies named in GRCE's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Aker BioMarine Antarctic AS | — | supplier | Counterparty in settlement agreement regarding supply agreement dispute and asset transfer. | 2023-10-23 | View |
| Acasti Pharma Inc. | ACST | acquirer | Acquiring company in the merger with Grace Therapeutics | 2021-05-07 | View |
| Grace Therapeutics, Inc. | GRCE | target | Target company being acquired by Acasti Pharma Inc. | 2021-05-07 | View |
| Acasti Pharma U.S., Inc. | — | partner | MergerCo, a wholly-owned subsidiary of Acasti Pharma Inc. | 2021-05-07 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-18 | Shareholder Vote | View | |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-08-06 | Material Agreement; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-07-28 | Other Events; Exhibits | View | |
| 2026-06-18 | Earnings Release; Exhibits | View | |
| 2026-06-18 | Other Events; Exhibits | View | |
| 2026-06-05 | Officer/Director Change; Exhibits | View | |
| 2026-04-27 | Other Events; Exhibits | View | |
| 2026-04-23 | Other Events; Exhibits | View | |
| 2026-02-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-12 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-10-23 | Other Events; Financial Statements and Exhibits | View | |
| 2025-09-18 | Other Events; Financial Statements and Exhibits | View | |
| 2025-09-12 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-08-27 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-25 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-23 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-09 | Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR